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Background: Methylphenidate (MPH) influences catecholaminergic signaling. Extant
work examined the effects of MPH on the neural circuits of attention and cognitive control,
but few studies have investigated the effect of MPH on the brain’s resting-state functional
connectivity (rsFC).
Methods: In this observational study, we compared rsFC of a group of 24 healthy adults
who were administered an oral 45mg dose of MPH with a group of 24 age and gender
matched controls who did not receive MPH. We focused on three seed regions: basal
nucleus of Meynert (BNM), locus coeruleus (LC), and ventral tegmental area/substantia
nigra, pars compacta (VTA/SNc), each providing cholinergic, noradrenergic and
dopaminergic inputs to the cerebral cortex. Images were pre-processed and analyzed
as in our recent work (Li et al., 2014; Zhang et al., 2015). We used one-sample t-test to
characterize group-specific rsFC of each seed region and two-sample t-test to compare
rsFC between groups.
Results: MPH reversed negative connectivity between BNM and precentral gyri.
MPH reduced positive connectivity between LC and cerebellum, and induced positive
connectivity between LC and right hippocampus. MPH decreased positive VTA/SNc
connectivity to the cerebellum and putamen, and reduced negative connectivity to left
middle occipital gyrus.
Conclusion:MPH had distinct effects on the rsFC of BNM, LC, and VTA/SNc in healthy
adults. These new findingsmay further our understanding of the role of catecholaminergic
signaling in Attention Deficit Hyperactivity Disorder (ADHD) and Parkinson’s disease and
provide insights into the therapeutic mechanisms of MPH in the treatment of clinical
conditions that implicate catecholaminergic dysfunction.
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INTRODUCTION
We seek to characterize the effects of methylphenidate (MPH)
on resting state functional connectivity (rsFC) in humans. This
study expands upon a previous work, which focused on the dorsal
striatum and thalamus (Farr et al., 2014a), by describing the
effects of MPH on the whole-brain rsFC of the basal nucleus of
Meynert (BNM), locus coeruleus (LC), and the ventral tegmental
area/substantia nigra pars compacta (VTA/SNc), each providing
cholinergic, noradrenergic (NA), and dopaminergic (DA) inputs,
respectively, to the cerebral cortex.
Low frequency, “spontaneous” blood oxygenation level
dependent (BOLD) signals are spatially organized and provide
valuable insights to the functional architecture of the brain (Fair
et al., 2007; Fox and Raichle, 2007). Brain regions involved in
similar tasks show correlated BOLD responses during rest. This
includes functional connectivity between regions associated with
sensorimotor processing, language, visual perception (Cordes
et al., 2000), memory (Vincent et al., 2006), and attention
(Fox et al., 2006a). A simple, sensitive measure of coordinated
regional brain activations, rsFC examines how individual voxels
are functionally related by increasing or decreasing activity
concurrently (Fox and Raichle, 2007). Using this method, we
previously delineated functional subdivisions in the medial
superior frontal cortex (Zhang et al., 2012), precuneus (Zhang
and Li, 2012) and the inferior parietal lobule (Zhang and Li,
2014), and characterized whole-brain functional connectivity of
the BNM and VS (Li et al., 2014) as well as the LC and VTA/SNc
(Zhang et al., 2015).
The current study focuses on subcortical nuclei that mediate
cholinergic and catecholaminergic signaling as these circuits are
of great importance to both basic and clinical neuroscience.
For instance, although MPH has been used to treat ADHD
and other clinical conditions since the 1950s (Lange et al.,
2010), research into its mechanism of action and effects on
brain function has only recently begun (for review, see Solanto,
1998; Advokat, 2010; Sahakian et al., 2015). We describe the
rationale of the study by focusing on the functional anatomy of
the cholinergic and catecholaminergic systems and how these
neurotransmitter systems are implicated in the pathophysiology
of neuropsychiatric conditions.
Basal Nucleus of Meynert (BNM)
The BNM provides cholinergic inputs to the hippocampus,
olfactory bulb, amygdala, and all of the neo-cortex (Pearson
et al., 1983; Rye et al., 1984; Richardson and DeLong, 1986).
Functionally, BNM is associated with memory formation
(Richardson and DeLong, 1988), attention, and the regulation
of arousal and sleep (Wenk, 1997). Selective inhibition of BNM
leads to memory deficits in rats (Voytko et al., 1994; Stoehr et al.,
1997; Tian et al., 2004), which are reversible with a cholinergic
agonist (Ridley et al., 1986) or catecholamine enzyme inhibitor,
suggesting an interaction between the catecholaminergic and
cholinergic systems (Khromova et al., 1995).
40% to 76% of BNM neurons are lost (Tagliavini and Pilleri,
1983) and choline acetyltransferase is diminished by 90% (Candy
et al., 1983) in Alzheimer’s disease (AD). Given the efficacy of
cholinergic treatments (Wilson et al., 1995; Bodick et al., 1997;
Rogers et al., 1998; Tariot et al., 2000), the loss of BNM volume
likely underlies cognitive dysfunction in AD. Patients with
Parkinson’s disease (PD) demonstrated a concurrent decrease in
choline acetyltransferase in the neocortex and in the number
of BNM neurons (Perry et al., 1985). Further, studies have
linked cholinergic deficits to catecholaminergic dysfunction in
these degenerative conditions. In AD, acetylcholine depletion
correlates with NA (Yates et al., 1983) as well as DA and
serotoninergic (Reinikainen et al., 1990) depletion.
The interaction of catecholaminergic and cholinergic systems
is also evident in other animal studies (Janowsky et al., 1974;
Tellez et al., 1999; Cucchiaro and Commons, 2003). Rats treated
with MPH exhibit stereotyped gnawing behavior, which can
be reduced with physostigmine, a cholinesterase inhibitor, both
pre- and post-treatment (Janowksy et al., 1972). A similar
antagonistic relationship between the two drugs was found in
human schizophrenia and mania patients, with physostigmine
and MPH each enhancing and impeding behavioral inhibition
(Janowsky et al., 1973). While it is not clear where in the neural
circuits these interactions transpire, the BNM receives direct
projections from the VTA/SNc (Gaykema and Zaborszky, 1996)
and modulates nigrostriatal circuit activity (Haber and Knutson,
2009). It is plausible that the DA and cholinergic systems
have cascading interactions at multiple levels of representations.
By addressing the effect of MPH on the cerebral functional
connectivity of the BNM, the present study would provide some
information on this issue.
Locus Coeruleus (LC)
LC is the largest source of NA neurons in the central nervous
system (CNS) (Moore and Bloom, 1979; Foote et al., 1983),
supporting arousal and cognitive functioning (Berridge and
Waterhouse, 2003; Aston-Jones and Cohen, 2005). Phasic LC
activation quickly follows presentation of target stimuli, precedes
the delivery of associated reward, and expresses an anticipation
signal (Aston-Jones et al., 1985, 1994), with concurrent
norepinephrine (NE) release in the cortex (Mountcastle et al.,
1972; Aston-Jones and Cohen, 2005). This phasic pattern of
activation resembles that found in the DA systems (Schultz et al.,
1997). In contrast, tonic baseline activity of the LC corresponds
with less efficient task-related behavior in animals (Aston-Jones
and Cohen, 2005) and may support exploration in situations
where the value of the task at hand has declined (Usher et al.,
1999). Projections to the LC from the orbitofrontal cortex (OFC)
and anterior cingulate cortex (ACC), areas critical to decision-
making (O’Doherty et al., 2003; Hare et al., 2008), may facilitate
switching between tonic and phasic modes of operation. MPH
increases NE levels in the LC and indeed throughout the brain
(Gatley et al., 1996; Kuczenski and Segal, 1997, 2002; Hannestad
et al., 2010). MPH reduces both tonic and phasic LC firing in
a dose-dependent manner, with more prominent effects at high
doses and a stronger effect on phasic than on tonic activity at low
doses (Devilbiss and Berridge, 2006).
MPH ameliorates impulsivity both in humans and non-
human primates (Rajala et al., 2012, 2015; Berridge and Arnsten,
2013). Thus, examining the effects of MPH on LC connectivity
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will advance our understanding of its neural mechanisms
in impulse control and MPH’s therapeutic effects in ADHD
(Volkow et al., 1995). Numerous studies revealed an important
role of NE in cognition. NA α-1-adrenoceptor antagonist
impairs working memory, particularly during induced stress
(Birnbaum et al., 1999). NA depletion impaired prefrontal
cortical function, which could be restored by NA α-2 agonists
(Arnsten et al., 1996). NA dysfunction is implicated in cognitive
deficits in Down syndrome (Salehi et al., 2009), schizophrenia,
and AD (Friedman et al., 1999). NE also plays a role in
affective memory; β-adrenoceptor antagonists impair memory
of emotional stimuli (Cahill et al., 1994). NE agents have
been widely used in the treatment of depression, with newer
medications increasing NE levels along with serotonin and/or
dopamine (Nelson et al., 2004; Stahl et al., 2004; Blier and
Szabo, 2005; Joffe et al., 2007). Thus, understanding the rsFC
of the LC would help advance our knowledge of the cerebral
NA system and its relevance to clinical conditions other than
ADHD.
Ventral Tegmental Area/Substantia Nigra,
Pars Compacta (VTA/SNc)
The VTA/SNc projects to the striatum and neocortex and
receives heavy glutamatergic projections from the ventromedial
prefrontal cortex (vmPFC), OFC, dorsal ACC (dACC), as
well as the hippocampus and amygdala (Haber and Knutson,
2009).
The DA pathway is a major component of the reward
system, a network of brain regions that predict and encode
value during reward-based processing and learning (Schultz
et al., 1997; O’Doherty et al., 2002; McClure et al., 2003; Aron
et al., 2005; Haber et al., 2006; D’Ardenne et al., 2008; Haber
and Knutson, 2009). Stimulants including MPH, atomoxetine
(ATX), and amphetamines influence glutamatergic signaling of
DA neurons in the VTA (Kalivas and Weber, 1988; Pert, 1998),
with repeated exposure leading to behavioral sensitization to
stimulants (Bonci and Williams, 1996; Pierce and Kalivas, 1997),
as also observed in humans (Prieto-Gómez et al., 2005; Jones
and Dafny, 2013). Psychostimulants may impact the brain via
connectivities to the VTA, with dysfunctional changes leading to
addiction.
MPH elicited increase in BOLD activity in the SN of rats
(Easton et al., 2009). In an arterial spin labeling study of humans,
MPH and ATX respectively increased and decreased regional
cerebral blood flow to the SN/midbrain (Marquand et al.,
2012). MPH also influences VTA/SN activation to behavioral
tasks, reversing responses to mental fatigue for both healthy
controls and cocaine abusing individuals (Moeller et al., 2012).
MPH blocks more than 50% of dopamine transporter and
significantly increases levels of extracellular DA in the basal
ganglia (Volkow et al., 1995, 1998, 2002). In fMRI, boys with
ADHD show increased, while healthy controls show decreased,
activity in the striatum under MPH (Vaidya et al., 1998). MPH
improves ADHD symptoms by increasing frontal and striato-
thalamic activation for inhibitory control (Rubia et al., 2011),
but it is unclear whether these effects are mediated by DA
projections from VTA (Shen and Choong, 2006; Warton et al.,
2009). Examining the influence of MPH on cerebral functional
connectivity of VTA/SNc will provide useful information on this
issue.
METHODS
Participants, study procedures, and imaging pre-processing were
described in detail in our recent work (Farr et al., 2014a).
Participants
Twenty-four healthy adults (16 females; age 25 ± 6 years)
participated in the study. All were without medical, neurological,
or psychiatric conditions, denied history of head injury and
current use of prescription medications or illicit substances,
and showed negative urinalysis on the day of fMRI. These 24
participants received a single 45mg oral dose of MPH before
fMRI and comprised the methylphenidate (MPH) group. Data
of a cohort of 24 matched healthy participants (16 females;
age 24 ± 4 years) scanned under identical imaging protocols
except without being given MPH were used for comparison—
the no-MPH group. Compared to baseline, MPH increased heart
rate, systolic blood pressure, and anxiety rating, as we reported
recently (Farr et al., 2014b). All participants provided written
consent following a protocol approved by the Yale Human
Investigation Committee.
Imaging Protocol and Data Analysis
Conventional T1-weighted spin-echo sagittal anatomical images
were acquired for slice localization using a 3T scanner (Siemens
Trio). Anatomical images of the functional slice locations were
next obtained with spin-echo imaging in the axial plane parallel
to the AC-PC line with TR= 300ms, TE= 2.5ms, bandwidth=
300 Hz/pixel, flip angle = 60◦, field of view = 220 × 220 mm,
matrix = 256 × 256, 32 slices with slice thickness = 4mm and
no gap. Functional, BOLD signals were then acquired with a
single-shot gradient echo echo-planar imaging (EPI) sequence.
Thirty-two axial slices parallel to the AC-PC line covering the
whole brain were acquired with repetition time = 2000ms, echo
time = 25 ms, bandwidth = 2004 Hz/pixel, flip angle = 85◦,
field of view = 220 × 220mm, matrix = 64 × 64, 32 slices
with slice thickness = 4mm and no gap. Three hundred images
were acquired in the resting state during which participants were
instructed to close their eyes but stay awake for a period of 10min
(Farr et al., 2014b).
Imaging Data Pre-Processing
Brain imaging data were pre-processed using the same routine
as described in our previous work (Zhang et al., 2012).
Briefly, images of each individual subject were first realigned
(motion corrected) and corrected for slice timing. A mean
functional image volume was constructed for each subject from
the realigned image volumes. The high-resolution structural
image was co-registered with these mean images and then
segmented for normalization with affine registration followed by
nonlinear transformation (Friston et al., 1995; Ashburner and
Friston, 1999). The normalization parameters determined for
the structural volume were then applied to the corresponding
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functional image volumes for each subject. Finally, the images
were smoothed with a Gaussian kernel of 8mm at full width at
half maximum.
Additional pre-processing was applied to reduce spurious
BOLD variances that were unlikely to reflect neuronal activity
(Rombouts et al., 2003; Fox et al., 2006a; Fair et al., 2007;
Fox and Raichle, 2007). The sources of spurious variance were
removed through linear regression by including the signal from
the ventricular system, the white matter and the whole brain,
in addition to the six parameters obtained by rigid body head
motion correction. First-order derivatives of the whole brain,
ventricular, and white matter signals were also included in the
regression. Following earlier studies (Cordes et al., 2001; Fox
and Raichle, 2007), we applied a temporal band-pass filter (0.009
Hz < f < 0.08 Hz) to the time course in order to obtain low-
frequency fluctuations (Fox et al., 2006b; Fair et al., 2007; Fox and
Raichle, 2007).
As extensively investigated by Van Dijk et al. (2012), we
applied a “scrubbing” method proposed by Power and colleagues
(Smyser et al., 2010; Power et al., 2012; Tomasi and Volkow,
2014) to remove time points affected by head motions: for every
time point t, we computed the framewise displacement given
by FD (t) =
∣
∣1dx (t)
∣
∣ +
∣
∣1dy (t)
∣
∣ +
∣
∣1dz (t)
∣
∣ + r |α (t)| +
r |β (t)| + r|γ (t) |, where (dx, dy, dz) and (α, β, γ ) are the
translational and rotational movements, respectively, and the
root mean square variance (DVARS) of the differences in %
BOLD intensity I(t) between consecutive time points across
brain voxels: DVARS (t) =
√
〈|I (t)− I(t − 1)|2〉. To compute
each subject’s correlation map, we removed every time point
that exceeded the head motion limit FD(t) > 0.5mm or
DVARS(t) > 0.5% (Power et al., 2012; Tomasi and Volkow,
2014). On average, 1% of the time points were removed across
subjects.
Seed Regions
We used the same seed regions as in our earlier work (Li et al.,
2014; Manza et al., 2015; Zhang et al., 2015), which are shown in
Figure 1.
Basal nucleus of Meynert (BNM)
A mask of the BNM was created based on a stereotaxic
probabilistic map of magnocellular cell groups in the basal
forebrain (Zaborszky et al., 2008), as detailed in our earlier
work (Li et al., 2014). Briefly, a T1-weighted MRI scan of
1.17 × 1 × 1mm was obtained of each individual brain
(n = 10) before histological processing. The outlines of various
basal forebrain compartments were traced on 2D images of
silver-stained (Merker, 1983) histological sections (20 µm thick,
1.2mm apart) with a resolution of 7000 × 6000 pixels. The
outlines were processed as contour line for each histological
section. As described in Zaborszky et al. (2008), we used a
modified version of the Ch1–Ch4 nomenclature of Mesulam
et al. (1983) to delineate the magnocellular basal forebrain cell
groups. Cell aggregates in the subcommissural–sublenticular
region largely correspond to the BNM as defined by Mesulam
et al. (1983); Vogels et al. (1990); De Lacalle et al. (1991);
Zaborszky et al. (2008).
Locus coeruleus (LC) and ventral tegmental area/substantia
nigra, pars compacta (VTA/SNc)
We used a probabilistic template of the LC derived by Keren
et al. (2009). The LC seed region represents the extent of peak LC
signal distribution, obtained from a sample of 44 healthy adults
(age range: 19–79 years) using high-resolution T1-weighted
Turbo Spin Echo (T1-TSE) MRI, and has a volume of 93mm3.
The T1-TSE LC signals were likely influenced by the ferrous
neuromelanin metabolites within LC neurons (Sasaki et al.,
2006) and observed in sections corresponding to the greatest
concentrations of LC cells in postmortem studies (German et al.,
1988). The VTA/SNc region was derived from the structural
MRIs of 30 healthy adults; after spatial normalization and
averaging across subjects, the size of the bilateral mask was
1106mm3 (Ahsan et al., 2007).
Seed-based Functional Connectivity: Linear
Correlations
The BOLD time courses were averaged spatially across all voxels
each for the three seed regions. We computed the correlation
coefficient between the averaged time course of each mask
and the time courses of individual voxels of the brain for
individual subjects. To assess and compare the resting state
“correlograms,” we converted these image maps, which were not
normally distributed, to z score maps by Fisher’s z transform
(Jenkins and Watts, 1968; Berry and Mielke Jr, 2000): z = 0.5
loge[(1+r)/(1−r)]. The z maps were used in group random effect
analyses (Penny et al., 2004) with a two- sample t-test to compare
MPH and no-MPH groups. All imaging findings were examined
with a peak voxel p< 0.001, uncorrected, combined with a cluster
threshold p < 0.05, corrected for family-wise error of multiple
comparisons.
RESULTS
The main results of the differences in rsFC between the two
groups are summarized in Figure 2 and Table 1.
Basal Nucleus of Meynert
MPH reversed negative connectivity between the BNM and
bilateral precentral gyri, including regions of the primary motor
and premotor cortex (Figures 2, 3; Table 1).
Locus Coeruleus
Both groups showed positive connectivity of LC with the bilateral
cerebellum, with the MPH group showing significantly less
positive connectivity. While the no-MPH group showed no
significant connectivity of LC with the right hippocampus, the
MPH group showed significant positive connectivity (Figures 2,
4; Table 1).
Ventral Tegmental Area/Substantia Nigra,
Pars Compacta (VTA/SNc)
While the no-MPH group showed negative VTA/SNc
connectivity with the left middle occipital gyrus (MOG),
the MPH group showed no significant connectivity. Both
groups showed positive VTA/SNc connectivity with bilateral
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FIGURE 1 | Seed regions: LC, locus coeruleus; VTA/SNc, ventral tegmental area, pars compacta; BNM, basal nucleus of meynert; VS, ventral striatum
(shown for contrast with the BNM; not examined in the current work).
cerebellum, with the MPH group showing lower connectivity
than the no-MPH group. While the no-MPH group showed
positive connectivity with bilateral putamen the MPH group
showed no significant connectivity (Figures 2, 5; Table 1).
Analyses without Global Signal Regression
in Data Pre-Processing
We re-analyzed the data without using global signal regression in
pre-processing. The findings showed that changes in functional
connectivity were slightly diminished in significance but were
otherwise similar. To confirm the findings, we extracted the effect
size of connectivity (in data without global signal regression)
of the ROIs as identified from the original analysis for
comparison between the MPH and no-MPH groups (Figure 2).
The results showed that the effect size of connectivity difference
remained highly significant: BNM—L Precentral Gyrus (p <
0.00001); BNM—R Precentral Gyrus (p < 0.00002); LC—
Cerebellum (p < 0.000001); LC—Hippocampus (p < 0.0004);
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FIGURE 2 | (A) Brain regions that show different connectivities between MPH
and noMPH groups; (B) Effect size (z-value) of rsFC of brain regions that show
different connectivities between MPH and noMPH groups. Values are mean ±
standard error; BNM, basal nucleus of Meynert; LC, locus coeruleus;
VTA/SNc, ventral tegmental area/substantia nigra pars compacta; PrG,
precentral gyrus; MOG, middle occipital gyrus; HC, hippocampus; MOG,
middle occipital gyrus; CB, cerebellum; PUT, putamen.
VTA/SNc—Cerebellum (p < 0.000001); VTA/SNc—Putamen (p
< 0.0012); and VTA/SNc—Left MOG (p< 0.0010).
DISCUSSIONS
Basal Nucleus of Meynert
Anatomically, VTA/SNc projects directly to the BNM (Gaykema
and Zaborszky, 1996). The dopamine-beta-hydroxylase and
tyrosine-hydroxylase containing axons meet the cholinergic
neurons, suggesting catecholaminergic modulation of
cholinergic activity (Zaborsky and Cullinan, 1996). BNM
provides cholinergic inputs to most of the cerebral cortex,
including the primary motor cortex (PMC; Pearson et al., 1983)
and receives projections from the OFC and VS (Mesulam and
Mufson, 1984), both of which are targets of DA projections
TABLE 1 | Brain regions that show different connectivities between MPH
and noMPH groups.
Cluster Voxel MNI Identified region
size Z-value coordinate (mm)
(mm3)
x y z
BNM CONNECTIVITY: MPH > noMPH
6507 4.20 −36 −28 70 L Precentral gyrus
4.10 −51 −22 58
4.09 −24 −31 76
7992 4.14 30 −31 70 R Precentral gyrus
3.85 48 −16 64
3.78 51 −16 43
BNM CONNECTIVITY: noMPH > MPH
None
LC CONNECTIVITY: MPH > noMPH
2484 4.71 27 −16 −17 R Hippocampal gyrus
3.44 15 −10 −23
3.43 36 −31 −5
LC CONNECTIVITY: noMPH > MPH
5373 4.70 12 −43 −50 R Cerebellum
3.90 9 −52 −50
3.67 −15 −46 −47 L Cerebellum
VTA/SNc CONNECTIVITY: MPH > noMPH
3537 4.40 −30 −82 −14 L Middle occipital gyrus
4.22 −48 −79 −5
3.36 −18 −88 −11
VTA/SNc CONNECTIVITY: noMPH > MPH
24,975 4.55 15 −52 −35 R Cerebellum
4.46 3 −73 −17
4.42 12 −82 −32
4104 4.24 −21 −1 13 L Putamen/Pallidum
3.76 −9 −13 13
All peaks greater than 8mm apart are identified. One voxel is 3 × 3 × 3mm3.
BNM, basal nucleus of Meynert; VS, ventral striatum; LC, locus coeruleus; VTA/SNc,
ventral tegmental area, pars compacta; p< 0.001 uncorrected and cluster-level threshold
of p < 0.05, FWE corrected.
and implicated in reward prediction, valuation, and decision-
making (Haber et al., 2006; Haber and Knutson, 2009).
Thus, MPH-induced increases in functional connectivity
between BNM and motor cortex may be mediated directly
by VTA/SNc DA projections or indirectly via the OFC
and VS.
MPH’s effects on the motor systems are well-documented.
MPH increased frontal activation in both healthy and ADHD
children (Vaidya et al., 1998). MPH increased the intensity and
decreased inhibition of motor responses in studies of transcranial
magnetic stimulation in both healthy individuals (Ilic et al., 2003)
and ADHD patients (Gilbert et al., 2005). MPH also increased
activity in lateral premotor areas in a four-choice reaction
time task (Müller et al., 2005). Additionally, basal forebrain
cholinergic outputs are required for motor learning. Lesions of
the rodent homolog of BNM depleted cholinergic innervation
to the cortex by more than 99% and led to slower and less
accurate responses in motor learning, but not in performing a
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FIGURE 3 | Regions with different functional connectivity to the BNM; Warm colors: MPH > no-MPH; Cool colors: MPH < no-MPH; voxel p < 0.001
uncorrected and cluster p < 0.05, FWE corrected. Color bars represent voxel T-value.
previously learned motor task (Conner et al., 2003, 2005, 2010).
Together, BNM and its cholinergic outputs to the motor cortex
are essential for motor control and learning, and MPH may
influence this process by reversing the negative BNM—motor
cortical connectivity.
MPH elicited reversal of the sign of BNM—motor cortical
connectivity may have treatment implications for PD. Combined
with levodopa (L-Dopa), MPH improves hand tapping speed
but worsens dyskinesia symptoms as compared to L-Dopa alone
(Camicioli et al., 2001). MPH alone improved reaction time in
a choice task (Camicioli et al., 2001) but may improve (Devos
et al., 2007; Moreau et al., 2012) or worsen (Espay et al., 2011) gait
symptoms in PD patients. These complexities need to be resolved
in the future.
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FIGURE 4 | Regions with different functional connectivity to the LC. Warm colors: MPH > no-MPH; Cool colors: MPH < no-MPH; voxel p < 0.001
uncorrected; and cluster p < 0.05, FWE corrected. Color bars represent voxel T-value.
Locus Coeruleus
MPH significantly reduced positive LC connectivity with specific
regions of the cerebellar cortex, likely lobules IV, V, and X
(Schmahmann et al., 2000). LC is the primary source of NA
projections to the cerebellum and cerebral cortex (Berridge and
Waterhouse, 2003). LC projects to the cerebellum via the superior
cerebellar peduncle (Moore and Bloom, 1979) and synapses with
inhibitory Purkinje cell dendrites in the Purkinje and molecular
layers (Ito et al., 1964; Hoffer et al., 1973; Moises andWoodward,
1980). Thus, MPH may alter activities of inhibitory Purkinje
cells in the cerebellum. Given that areas of the cerebellum are
specialized for fine-tuning of motor control and/or calibration
of motor output (Middleton and Strick, 2000), it is possible
that MPH’s effect on the reduction of positive connectivity
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FIGURE 5 | Regions with different functional connectivity to the VTA/SNc. Warm colors: MPH > no-MPH; Cool colors: MPH < no-MPH; voxel p < 0.001
uncorrected; and cluster p < 0.05, FWE corrected. Color bars represent voxel T-value.
represents a shift away from fine in favor of gross motor
function.
It has been suggested that long-term potentiation (LTP) in the
hippocampus is mediated by NA activity (Ramos and Arnsten,
2007). Increases in NE, as elicited by an alpha-1-adrenergic
agonist, significantly increased LTP in the hippocampus (Izumi
and Zorumski, 1999). MPH increases NE levels (Weikop
et al., 2007) and enhances both LTP and long-term depression
in the hippocampus, both of which were blocked by a
beta-noradrenoceptor antagonist (Dommett et al., 2008). Thus,
MPH-evoked increases in LC connectivity to the hippocampus
may alter learning and memory.
Indeed, MPH improved 1-week retention of both casually
and intentionally learned information when administered 12
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h after learning (Izquierdo et al., 2008). When administered
before testing, MPH improved word recall, but not spatial
working memory in healthy adults (Verster et al., 2010; Linssen
et al., 2012). In contrast, MPH appears to reduce emotional
memory despite producing increased arousal for emotional
stimuli (Brignell et al., 2007). Polymorphisms of Catechol-
O-methyltransferase (COMT) gene have been associated with
different degrees of cognitive improvements under amphetamine
(Mattay et al., 2003), highlighting inter-subject variation in the
effects of psychostimulants on cognitive functions.
Ventral Tegmental Area/Substantia Nigra,
Pars Compacta (VTA/SNc)
Thus, MPH diminishes negative connectivity between VTA/SNc
and left MOG. While the prefrontal cortex receives both direct
NE and DA projections, the occipital cortex receives scarce DA
projections in the rat (Descarries et al., 1987; Lidow et al., 1991;
Devoto et al., 2001). On the other hand, extra-cellular DA in the
rat occipital cortex is only 37% lower than that in the mPFC
(Devoto et al., 2003). In this same study, when an NE antagonist
was injected into LC, NE, and DA levels in the occipital cortex
fell 50 and 70%, respectively (Devoto et al., 2003). Conversely, a
NE-agonist increased both occipital NE and DA (Devoto et al.,
2004). Combined, these results suggest that occipital cortical DA
may originate from co-release of DA and NE from LC neurons
(Devoto et al., 2003, 2004).
It is plausible that MPH diminishes negative connectivity
between VTA/SNc and the MOG as a result of complex
interaction of NA and DA systems. Further, DA projections to
cortex are more abundant in primates including humans than in
rats (Björklund and Dunnett, 2007); for example, varying levels
of DA-receptor mRNA have been found in the human occipital
cortex, with D1 and D3 receptor transcripts being the most and
least prominent, respectively (Meador-Woodruff et al., 1996).
Further research should clarify this interaction and investigate its
effect on behavior.
Many studies have implicated the MOG in ADHD. In
diffusion tensor imaging (DTI), ADHD patients show reductions
in trace (a measure of diffusion magnitude) in the left MOG
(Alexander et al., 2007; Chaim et al., 2014). More specifically,
children with ADHD inattentive subtype exhibit increased radial
diffusivity (diffusion perpendicular to fiber direction) compared
to healthy controls (Lei et al., 2014). Lower fractional anisotropy
in the fronto-occipital fasciculus is correlated with greater
inattention symptoms in ADHD adults (Shaw et al., 2014).
Functional differences in the MOG are also associated with
ADHD. Visual regions including theMOG show decreased nodal
efficiency during a working memory task in ADHD based on a
“small-world” regime (Xia et al., 2014). In activation likelihood
estimation meta-analysis, the MOG is less likely to be active in
ADHD patients during executive function compared to controls
(Dickstein et al., 2006). Thus, one is tempted to speculate that the
treatment effects of MPH in ADHDmay at least in part be related
to functional connectivity between the MOG and VTA/SNc.
MPH reduced positive connectivity between VTA/SNc and
multiple areas of the dorsomedial cerebellum including the
vermis, culmen, and medial hemispheres. The cerebellum is
important to cognition and motor control, with distinct areal
connections to motor and prefrontal cortices (Middleton and
Strick, 2000). The medial cerebellar cortex and dorsal cerebellar
nuclei are more involved in motor coordination than lateral
cerebellar hemispheres and ventrolateral cerebellar nuclei, which
are more involved in learning and cognition (Jueptner et al.,
1997a,b). Thus, the reduction in VTA/SNc positive connectivity
to the vermis, culmen, and medial cerebellum may suggest a
damping effect of MPH on motor activity.
Acute stimulation of the VTA/SNc increases cFOS
immunoreactivity, an indirect measure of brain activity, in the
dorsal cerebellum, and chronic DA antagonism decreased cFOS
in the dorsal vermis while increasing it in the dorsal cerebellar
hemisphere (Herrera-Meza et al., 2014). Administration of
dextroamphetamine, a competitive DA agonist, increases activity
in the dorsomedial cerebellum (Ernst et al., 1997; Schouw
et al., 2013). While studies have shown a relative lack of DA in
the cerebellum compared to the basal ganglia (Wagner et al.,
1983; Martres et al., 1985; Jucaite et al., 2006), other work has
uncovered anatomical connections between VTA and cerebellum
(Ikai et al., 1992) as well as tyrosine hydroxylase- and dopamine
transporter-immunoreactive axons (Melchitzky and Lewis,
2000), DA D5 receptors (Khan et al., 2000), and DA neurons
(Hurley et al., 2003), supporting potential actions of the MPH in
the cerebellum.
Cerebellum has been implicated in catecholaminergic
dysfunction. Mice generated with decreased levels of monoamine
oxidase A (MAO-A), an enzyme integral to maintaining
normal catecholamine levels, exhibit smaller cerebellums,
decreased Purkinje cell count and dendritic density, and vermal
hypoplasia (Alzghoul et al., 2012). MAO-A/B knockout mice
also show enhanced eye-blink conditioning, which depends on
cerebellar integrity, suggesting another critical cerebellar process
contingent on catecholaminergic signaling (Singh et al., 2013).
The link between catecholaminergic function and the
cerebellum may lead to new insights in treating motor disorders
like PD. DA signaling from the striatum, as well as input from
the cerebellum, influences the plasticity of the PMC duringmotor
learning, a process known to be abnormal in PD (Kishore et al.,
2014). Also, a model for the dyskinesia symptoms caused by
levodopa, a common treatment for PD, implicates dysfunctions
in cerebellar modulation of sensory projections to the PMC
(Kishore et al., 2014; Kishore and Popa, 2014). In the latter
hypothesis DA regulation is critical to proper cerebellar and
motor function as a whole, and supports the influence of MPH
on cerebellar connectivity.
MPH increases cerebellar activity in both ADHD adults and
children (Epstein et al., 2007), and restores cerebellar response
during successful response inhibition (Rubia et al., 2011). A T2
relaxometry study, which uses T2 relaxation time to estimate
cerebral blood flow, also suggests a normalizing effect of MPH
on cerebellar activity in ADHD, with hyperactive and non-
hyperactive subjects, respectively, exhibiting an increase and
decrease in T2 relaxation time under MPH (Anderson et al.,
2002). In a non-ADHD population, MPH significantly increases
metabolic activity in the cerebellum of cocaine addicts, and
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D2 receptor availabilities are significantly correlated with the
increase in metabolism (Volkow et al., 1999). These results again
support our finding of significant interaction between MPH
and VTA/SNc-cerebellum connectivity. With the link of the
cerebellum to execution of learned motor tasks (Jueptner et al.,
1997a), as well as memory (Imamizu et al., 2000) and recall
(Shadmehr and Holcomb, 1997) of motor skills, MPH’s effect
may underlie reductions in hyperactivity in ADHD (Cohen et al.,
1971), and/or represent a more global shift to support cognitive
over motor functions.
Limitations and Conclusions
Several issues should be considered. First, this observational
study is based on a between-subjects design and did not involve
a placebo control; thus, the placebo effect may confound the
results. Further, we did not control for individual differences
such as personality traits and pharmacokinetics, which may
underlie variability of the effects of MPH. Thus, although the
MPH and no-MPH groups are also individually matched in
age and gender, the current results should be considered as
preliminary and require replication in future work with a within-
subject design. Second, the LC seed is very small. Although our
recent study examined and negated the influence of physiological
signals on BOLD activity and functional connectivity of the
LC (Zhang et al., 2015), more studies with higher field
magnet are needed to provide the spatial resolution needed to
confirm the current findings. Third, we did not include any
assessment of cognitive or motor performance, so the functional
implications of our findings need to be reconsidered in follow-up
work.
In summary, MPH had varying effects on the functional
connectivity of BNM, LC, and VTA/SN. MPH reversed negative
BNM connectivity with bilateral precentral gyrus, in accord with
its effects onmotor control and learning in ADHD and PD.MPH
decreased positive connectivity between LC and cerebellum,
whichmay underlie priming for cognitive over motor processing.
MPH increased connectivity between LC and hippocampus, a
change that may underlie reported improvements in memory.
MPH eliminated or nearly eliminated connectivity of VTA/SNc
with the cerebellum, putamen and left MOG, suggesting a DA
mechanism of its effects on cognitive motor processing and visual
attention. However, the current findings are obtained in healthy
individuals and may not readily generalize to neuropsychiatric
populations.
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